Study design and participants Eight lactating women participated
Together, we will create a plan to monitor your progress , support your goals, and empower you with sustainable strategies for lifelong health
There is a sentence that stopped me when I first read the phase 2 data: 100% of participants in the 8 mg and 12 mg groups lost at least 5% of their body weight
GLP-1 medications often lead to : - Rapid weight loss - Significant muscle loss - Metabolic slowdown : True fat loss, on the other hand True fat loss, on the other hand - Preserves lean muscle - Supports metabolic health - Improves body composition - Is far more sustainable The Long-Term Risk Most People Arent Told About When muscle mass is lost : - Blood sugar control worsens over time - Insulin sensitivity can decline - Functional strength decreases - Risk of injury increases - Quality of life declines with age Ironically, the very medications designed to improve metabolic health may undermine it long term if muscle loss is not addressed
These same practices maintain your new body composition when the pharmaceutical support ends
NF-B promotes tumor cell survival by upregulating a variety of anti-apoptotic proteins, including Bcl-2 family proteins and cell cycle regulators [68]